Ads
related to: pharmaceutical industry news
Search results
Inventing Drugs Is One of the Most Exciting Uses of AI
Bloomberg· 5 days agoLisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical ...
Earnings call: Rigel Pharmaceuticals Q1 2024 performance and outlook
Investing.com· 7 days agoThe company also announced the acquisition of GAVRETO, a therapy approved for specific types of...
Earnings call: Teva Pharmaceuticals reports growth and pipeline progress By Investing.com
Investing.com· 5 days agoTeva Pharmaceuticals Industries Ltd. (TEVA) held its first quarter 2024 earnings conference call,...
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024 - WTOP News
WTOP Washington· 4 days agoNEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen Inc., up $8 to $31.56. The salad restaurant chain beat analysts' first-quarter revenue forecasts.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to...
Digital Journal· 1 day agoFounded and staffed by newswire veterans, we offer a full complement of distribution services for financial news and filings, national and global announcements, and rich multimedia ...
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its...
Simply Wall St. via Yahoo Finance· 3 days agoOn the negative side, they also downgraded their revenue estimates, and forecasts imply they will...
Earnings call: Cipher Pharmaceuticals reports strong Q1 with revenue up 20% By Investing.com
Investing.com· 4 days agoCipher Pharmaceuticals (OTC:CPHRF) Inc. (TSX:CPH) has released its Q1 2024 financial results,...
AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com
Investing.com· 10 hours agoOn Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...
Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 6 days agoThe key question for investors is how Teva Pharmaceutical Industries’ pipeline of new medicines...
Earnings call: Mirum Pharmaceuticals reports robust Q1 growth By Investing.com
Investing.com· 2 days agoMirum Pharmaceuticals (ticker: NASDAQ:MIRM) has reported a significant increase in financial results...